Abstracts tagged "EMRAI and Clinical Characteristics"

Abstract Number: 1700 • 2019 ACR/ARP Annual Meeting
Clinical Characteristics and the Level Disease Activity of Behcet´s Disease in China: A Study Based on Smart System of Disease Management (SSDM)
Lingli Dong¹, Shouxin Li ¹, Fen Wang ², Zhenbiao Wu ³, Shengtao Zhang ¹, Qin Li ⁴, Henglian Wu ⁵, Zhengang Wang ⁶, Huifang Guo ⁷, Yikai Yu ¹, LingXun Shen ⁸, Yasong Li ⁹, Yang Liu ¹⁰, Tian Wang ¹¹, Peng Ji ¹², Zongwen Shuai ², Hongbin Li ¹³, Li Luo ¹², Hui Xiao ¹⁴, Yuhua Jia ¹⁵, Bing Wu ¹⁶, Shengsong Jia ¹⁵, Fei Xiao ¹⁷ and Lijun Wu ¹⁸, ¹Tongji Hospital，Tongji Medical Colllege，Huazhong University of Science and Technology, Wuhan, Hubei, China (People's Republic), ²First Affiliated Hospital of Medical University Of Anhui, Hefei, Anhui, China (People's Republic), ³The First Affiliated Hospital of The Fourth Military Medical University, Xian, Shanxi, China (People's Republic), ⁴The First People's Hospital of Yunnan Province, Kunming, Yunnan, China (People's Republic), ⁵Dongguan donghua hospital, Dongguan, Guangdong, China (People's Republic), ⁶TongRen hospital,Capital University, Bei Jing, China (People's Republic), ⁷The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), ⁸Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), ⁹Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China (People's Republic), ¹⁰Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Nei Mongol, China (People's Republic), ¹¹Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China (People's Republic), ¹²The first affiliated hospital of xinjiang medical university, Urumchi, China (People's Republic), ¹³The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Nei Mongol, China (People's Republic), ¹⁴Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ¹⁵Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ¹⁶Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ¹⁷Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic), ¹⁸People's Hospital of Xinjiang Uygur Autonomous region, Wulumuqi, Xinjiang, China (People's Republic)
Background/Purpose: Behcet´s disease (BD) is a systemic autoimmune disease that affects multiple organ systems with recurrent oral ulcers, genital ulcers and skin lesions, which might…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].